Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Regulatory News (VAL)

Share Price Information for ValiRx (VAL)

Share Price is delayed by 15 minutes
Get Live Data
0.185    -0.005 (-2.63%)
Bid:
0.18
Ask:
0.19
Spread: 0.01 (5.556%)
Market Cap: £1.37m
VAL Live PriceLast checked at - London Stock Exchange

Intraday ValiRx Share Chart

Directorate Change

12 May 2006 14:49

Azure Holdings PLC12 May 2006 Azure Holdings plc (the "Company") Board changes The Company announces the appointment of Barry Gold and Gerald Desler asdirectors of the Company, and the resignation of the existing directors,Nicholas Greenstone and Ronald Stirling, with immediate affect. Barry Gold, age 58, is a solicitor with experience of fully listed andAIM-quoted companies. Mr Gold is currently the chairman and joint managingdirector of Premier Management Holdings plc, an AIM-quoted football agency. Mr Gold's current directorships are as follows: BG Consultancy Services Limited, Matisse Holdings plc, Nemesis Marketing Groupplc, Premier Management Holdings plc, Premier Management Recruitment Limited,Premier Management Snooker Limited, Venture Six plc. In the past five years Mr Gold has been a director of the following companies: Aimwright Limited, Apollo Metals plc, Avent Limited, Avent Enterprises Limited,Bracken Partners Limited, Bracken Partners Group Limited, Cannon Avent Groupplc, Cannon Avent Limited, Capitol Group plc, Dudley Jenkins Group plc, EssexFurniture plc (1), Hopeflow Properties Limited, Kingstonian Football ClubLimited, London Asia Capital plc, Moving Homes Limited, Non-League Media plc(2), Pure Holdings Limited, Southern Homes & Properties Limited, TimeframedLimited (3), Underwriting and Subscription plc, Yorkplan Limited. (1) Mr Gold was a non-executive director at the time of or within the 12 monthspreceding the administrative receivership of Essex Furniture plc which occurredin October 1998. At the time the administration order was made for EssexFurniture plc in October 1998, the estimated deficiency with regards tocreditors was £17,044,308. The majority of this related to estimated rents duein respect of the remaining terms of leases, all but two of which by December1999 had either been assigned or returned to the landlords; customers' deposits,where the goods have now been substantially delivered; and a VAT repayment of£2.35 million. (2) Mr Gold was also a non-executive director at the time of or within the 12months preceding the administrative receivership of Non-League Media plc, whichoccurred in June 2002. At the time the administration order was granted, theestimated deficiency with regards to creditors was £116,999. (3) Mr Gold was also a non-executive director at the time of or within the 12months preceding the insolvent liquidation of Timeframed Limited, which occurredin November 2001. At the time of the appointment of the liquidator to TimeframedLimited, the deficiency as regards to creditors was £8,361,386, of which£4,500,000 was in respect of loan stock holders; £3,000,000 was owed to thefounder; £41,512 to preferential creditors; and £423,586 to unsecured creditors. Mr Gold was a non-executive director at the time of or within the 12 monthspreceding the administrative receivership of Clearmark Group plc, which occurredin August 1991. The receivers ceased to act for Clearmark Group plc in 1998,which was subsequently dissolved by notice in the London Gazette, dated 20 April1999. Gerald Desler, age 60, is a chartered accountant, who qualified in 1968 withStanley A Spofforth & Co., becoming a partner in 1970 and a senior partner in1985. Mr Desler is currently the finance director of Premier Management Holdingsplc. Mr Desler's current directorships are as follows: 140 High Street Management Limited, Andrew Manning Limited, Andrew MillsConsultancy Limited, Aralbest Limited, Babble.net Group plc, BG ConsultancyServices Limited, C&R Civil Enforcement Services Limited (4), Click 4 SupportLimited, Desler Consulting Limited, Managed Services Solutions Limited, MSCAgency Limited, Premier Management Football Limited, Premier Management Holdingsplc, Premier Management Recruitment Limited, Southern Homes & PropertiesLimited, Sports Player Management Limited (5), Student Link plc, Tangent MediaGroup Limited, Venture Six plc, In the past five year's Mr Desler has been a director of the following: Global Screen Ad Services Limited, Global Screen Ad Systems Limited, KingstonianFootball Club Limited, Milefarm Limited, Noviceguru Limited, Resday Limited,Signactual Limited, The Online Shop Web Fulfilment Limited, Theonlineshop.co.ukLimited, Theonlineshop.TV Limited, Yorkplan Limited (4) On 9 August 2001, Mr Desler was appointed a director of C&R CivilEnforcement Services Limited. A liquidator was appointed on 18 October 2004. Theliquidation is ongoing. (5) Mr Desler is a director of Sports Player Management Limited which went intoliquidation in April 2006. The liquidation is ongoing. Mr Desler was a director of Grovefair plc, which went into voluntaryreceivership in March 1997. He had resigned as a director on 31 March 1996.Following his resignation as a director of Grovefair plc, it undertook areorganisation whereby it was divided into two separately owned entities. WhileGrovefair plc went into voluntary receivership, the other entity did not. There are no further disclosures required under Schedule Two (g) of the AIMrules. For further information please contact: Barry Gold, Azure Holdings plc Tel: 07768 948 928David Youngman, WH Ireland Limited Tel: 0161 832 2174 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Jun 20267:00 amRNSConclusion of Evaluation with Stingray
1st Jun 20267:00 amRNSValiRx Exercises Option on Evaluation Asset
27th May 20267:00 amRNSCytolytix Patent Granted
21st May 20267:00 amRNSResult of Oversubscribed WRAP Retail Offer
18th May 20267:00 amRNSWRAP Retail Offer for up to £150,000
15th May 20267:00 amRNSFundraising of up to £1,155,000
31st Mar 202610:15 amRNSChange of Registered Office
26th Mar 20267:00 amRNSValiRx Commercial Update Q1 2026
24th Mar 20267:00 amRNSValiRx and TwinEdge to present Digital Twin data
4th Mar 20267:00 amRNSDirector/PDMR Shareholding
2nd Mar 20267:00 amRNSValiRx forms ValiRx Animal Health Ltd subsidiary
19th Jan 20267:00 amRNSExercise of Warrants
9th Jan 20263:45 pmRNSReplacement: Evaluation and Transfer Agreement
9th Jan 20267:00 amRNSNew Evaluation and Material Transfer Agreement
8th Jan 20261:00 pmRNSHolding(s) in Company
5th Dec 202510:56 amRNSHolding(s) in Company
24th Nov 20253:54 pmRNSHolding(s) in Company
24th Nov 20259:30 amRNSHolding(s) in Company
20th Nov 202512:11 pmRNSResult of GM & Issue of Equity
13th Nov 20252:16 pmRNSHolding(s) in Company
10th Nov 20257:00 amRNSHolding(s) in Company
4th Nov 20255:15 pmRNSPosting of Circular and Notice of General Meeting
4th Nov 20257:00 amRNSResult of WRAP Retail Offer
30th Oct 20257:21 amRNSWRAP Retail Offer for up to £300,000
30th Oct 20257:17 amRNSFundraising of up to £1,050,000
14th Oct 20257:00 amRNSInaphaea Commercial update
29th Sep 20257:00 amRNSHalf-year Report
18th Sep 20257:00 amRNSInaphaea Commercial Update
1st Sep 20257:00 amRNSCytolytix Commercial update
26th Aug 20257:00 amRNSCommercial update
7th Aug 202510:51 amRNSValiRx Awarded Grant from Open University
5th Aug 20259:53 amRNSUpdate on Evaluation Agreement with Stingray Bio
4th Aug 20257:00 amRNSLicensing Agreement with Dominion Biotech Ltd
29th Jul 20257:00 amRNSCollaboration Agreement with Voxcell BioInnovation
30th Jun 20253:48 pmRNSResult of AGM
20th Jun 20257:00 amRNSAmbrose Exercise Option on VAL401
9th Jun 202510:57 amRNSValiRx Investor Webinar
6th Jun 202510:54 amRNSHolding(s) in Company
6th Jun 20257:00 amRNSFinal Results & Notice of AGM
3rd Jun 20257:00 amRNSNew Evaluation and Material Transfer Agreement
20th May 20251:25 pmRNSHolding(s) in Company
12th May 20257:00 amRNSInaphaea Deal Extension With Dominion
30th Apr 20257:00 amRNSCommercial Update
3rd Apr 20257:00 amRNSTermination of Letter of Intent with TheoremRx
27th Mar 20257:00 amRNSDirectorate Changes and new Advisory Board
21st Mar 202511:07 amRNSDirector Disclosure Update
24th Feb 20257:00 amRNSConclusion of Evaluation Project
3rd Feb 20257:00 amRNSInaphaea Evaluation and Commercial Use Agreement
30th Jan 20257:00 amRNSExtension of Evaluation Agreement
29th Jan 20257:00 amRNSNew Evaluation and Option Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.